| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, Worldwide R&D | EVP, Chief Medical Officer
1 company
Fuchs Henry J is a President, Worldwide R&D at BMRN. Recent filings cover 0 purchases and 30 sales. Those positions are worth an estimated $15.7M at current prices.
Fuchs Henry J's largest disclosed position is in BMRN as President, Worldwide R&D, worth about $15.7M. The recent filings there lean toward selling, a net 422,679 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2024 | BMRN Biomarin Pharmaceutical Inc | President, Worldwide R&D | Sell | 35,341 | $85.18 | $3,010,395.86 | -14.3% | -11.2% | -17.2% | |
| Aug 10, 2023 | BMRN Biomarin Pharmaceutical Inc | President, Worldwide R&D | Sell | 12,000 | $90.43 | $1,085,110.80 | -6.4% | -5.9% | -2.5% | |
| Jul 20, 2020 | BMRN Biomarin Pharmaceutical Inc | President, Worldwide R&D | Sale+OE | 126,389 | $130.00 | $16,430,570.00 | -55.1% | - | - | |
| Jul 13, 2020 | BMRN Biomarin Pharmaceutical Inc | President, Worldwide R&D | Sale+OE | 23,011 | $130.00 | $2,991,430.00 | -18.3% | - | - | |
| Apr 24, 2020 | BMRN Biomarin Pharmaceutical Inc | President, Worldwide R&D | Sell | 20,000 | $95.88 | $1,917,617.48 | -16.3% | - | - | |
| Apr 20, 2020 | BMRN Biomarin Pharmaceutical Inc | President, Worldwide R&D | Sell | 17,213 | $90.00 | $1,549,170.00 | -12.3% | - | - | |
| Mar 25, 2019 | BMRN Biomarin Pharmaceutical Inc | President, Worldwide R&D | Sell | 5,932 | $87.86 | $521,185.52 | -4.5% | - | - | |
| Mar 18, 2019 | BMRN Biomarin Pharmaceutical Inc | President, Worldwide R&D | Sell | 9,597 | $94.09 | $902,981.73 | -6.6% | - | - | |
| Mar 4, 2019 | BMRN Biomarin Pharmaceutical Inc | President, Worldwide R&D | Sell | 2,196 | $95.00 | $208,620.00 | -1.5% | - | - | |
| Aug 27, 2018 | BMRN Biomarin Pharmaceutical Inc | President, Worldwide R&D | Sell | 25,000 | $99.50 | $2,487,500.00 | -16.1% | - | - |